The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: Groningen International Study on Sentinel Nodes in Vulvar Cancer III (GROINSS-V III/NRG-GY024).
 
Lilian Tran Gien
Honoraria - Merck
Consulting or Advisory Role - Corcept Therapeutics; GlaxoSmithKline Canada; Jazz Pharmaceuticals; Merck; Myriad Genetics; Toray Industries
 
Brian M. Slomovitz
Consulting or Advisory Role - Agenus; AstraZeneca; Clovis Oncology; Eisai; EQRx; Genentech; GlaxoSmithKline; GOG Foundation; Incyte; Merck; Myriad Genetics; Nuvation Bio; Onconova Therapeutics; Regeneron
 
Mario M. Leitao
Honoraria - Intuitive Surgical
Consulting or Advisory Role - Ethicon/Johnson & Johnson; Intuitive Surgical; Medtronic; Takeda
Research Funding - KCI
Travel, Accommodations, Expenses - Intuitive Surgical
 
Ate Van Der Zee
No Relationships to Disclose
 
Carien L. Creutzberg
Consulting or Advisory Role - Merck (Inst)
Research Funding - Elekta (Inst); Varian Medical Systems (Inst)
 
An K.L Reyners
No Relationships to Disclose
 
Petronella Witteveen
No Relationships to Disclose
 
Diandra Ayala-Peacock
Employment - Piedmont Triad Anesthesia (I)
Consulting or Advisory Role - Boston Scientific
 
Jyoti Mayadev
No Relationships to Disclose
 
Charles A. Leath
Consulting or Advisory Role - Abbvie; Clovis Oncology; GlaxoSmithKline; Immunogen; Merck; Natera; Seagen
Research Funding - Abbvie (Inst); Agenus (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Celsion (Inst); Corcept Therapeutics (Inst); Immunogen (Inst); Incyte (Inst); Merck (Inst); Rubius Therapeutics (Inst); Seagen (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Eisai
 
Maaike Oonk
No Relationships to Disclose